J0630
J0630 – Injection, calcitonin salmon, up to 400 units · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 9 NDCs crosswalked
📋 J0630 summary
J0630 is a HCPCS Level II J-code used to bill calcitonin salmon, up to 400 units. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J0630: Calcitonin-Salmon*, Calcitonin Salmon, Miacalcin
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ0630
DescriptorInjection, calcitonin salmon, up to 400 units
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs9
Data periodNot available in current dataset
Last updatedSource date not available
💊 About Calcitonin Salmon Injection DRUG GUIDE
Miacalcin (calcitonin salmon) injection is used for three conditions.
It treats symptomatic Paget's disease of bone — a condition where bones break down and rebuild abnormally — in moderate to severe cases.
It is also used for the urgent treatment of hypercalcemia (dangerously high calcium levels in the blood), often alongside other therapies, to bring calcium down quickly.In addition, Miacalcin injection is used for postmenopausal osteoporosis in women who are more than 5 years past menopause and for whom other treatments are not suitable.
It has been shown to increase total body calcium, but it has not been proven to reduce fractures.
Clinical overview from our editorial drug guide for Calcitonin Salmon Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS
Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionInjection, calcitonin salmon, up to 400 units
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date1997-01-01
Date added1982-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J0630 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J0630 CROSSWALKED NDCs
9 NDCs map to J0630. Bill units = how many HCPCS units one package represents.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|
| 25021-0473-02 | Calcitonin Salmon 400 [USP'U]/2mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-473-02) / 2 mL... | 400 [USP'U]/2mL | 0.5 | — | ● Active | PDAC |
| 63323-0865-02 | Calcitonin Salmon 200 [iU]/mL INJECTION, SOLUTION | Fresenius | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-865-... | 200 [iU]/mL | 0.5 | — | ● Active | PDAC |
| 69097-0770-32 | CALCITONIN SALMON 200 [USP'U]/mL INJECTION, SOLUTION | Cipla | 1 VIAL, MULTI-DOSE in 1 CARTON (69097-770-... | 200 [USP'U]/mL | 0.5 | — | ● Active | PDAC |
| 43598-0051-11 | Calcitonin Salmon 200 [USP'U]/mL INJECTION, SOLUTION | Dr. | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-051-... | 200 [USP'U]/mL | 0.5 | — | ● Active | PDAC |
| 72078-0039-02 | Miacalcin calcitonin salmon 200 [USP'U]/mL INJECTION, SOLUTION | Mylan | 1 VIAL, MULTI-DOSE in 1 CARTON (72078-039-... | 200 [USP'U]/mL | 0.5 | — | ● Active | PDAC |
| 72078-0038-02 | Miacalcin calcitonin salmon 200 [USP'U]/mL INJECTION, SOLUTION | Mylan | 1 VIAL, MULTI-DOSE in 1 CARTON (72078-038-... | 200 [USP'U]/mL | 0.5 | — | ● Active | PDAC |
| 42023-0205-01 | Calcitonin Salmon 200 [iU]/mL INJECTION, SOLUTION | Par | 1 VIAL, MULTI-DOSE in 1 CARTON (42023-205-... | 200 [iU]/mL | 0.5 | — | ● Active | PDAC |
| 24201-0400-02 | Calcitonin Salmon 200 [USP'U]/mL INJECTION, SOLUTION | Hikma | 1 VIAL, MULTI-DOSE in 1 CARTON (24201-400-... | 200 [USP'U]/mL | 0.5 | — | ● Active | PDAC |
| 67457-0675-02 | Miacalcin calcitonin salmon 200 [USP'U]/mL INJECTION, SOLUTION | Mylan | 1 VIAL, MULTI-DOSE in 1 CARTON (67457-675-... | 200 [USP'U]/mL | 0.5 | — | ● Active | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2025 (Q1-Q4)
Total Part B spend
$1.18M
Claims
136
Beneficiaries
49
Spend / beneficiary
$24,152.45
Spend / claim
$8,701.98
Where J0630 ranks among Part B drugs · 2025 (Q1-Q4) · neighbors ±5
Total spending — #549 of 918
#544
EDETATE CALCIUM DISO... J0600
$1.3M
#545
SUBLOCADE(Q9991) Q9991
$1.29M
#546
CUBICIN RF* J0878
$1.27M
#547
ALDURAZYME J1931
$1.27M
#548
SUBLOCADE(Q9992) Q9992
$1.26M
#549
CALCITONIN-SALMON* J0630
$1.18M
#550
RYLAZE J9021
$1.18M
#551
IPRATROPIUM BROMIDE J7644
$1.17M
#552
SUNLENCA J1961
$1.17M
#553
PYRIDOXINE HCL J3415
$1.16M
#554
ETOPOSIDE J8560
$1.15M
Total claims — #760 of 918
#755
ESPEROCT J7204
145
#756
AMNIPLY, PER SQ CM** Q4249
144
#757
ALLOPLY, PER SQ CM** Q4323
143
#758
TEMODAR J9328
140
#759
FLUMIST * 90660
138
#760
CALCITONIN-SALMON* J0630
136
#761
CHLOROPROCAINE HCL* J2401
135
#762
SIVEXTRO J3090
135
#763
PROGRAF(J7525)* J7525
132
#764
PEMETREXED(J9323) J9323
132
#765
BIZENGRI J9382
130
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (1)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2025 (Q1-Q4) | $1.18M | 49 | 136 | $24,152.45 | $8,701.98 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$0.00
Medicare paid
$0.00
Submitted services
11
Denial rate
100.0%
Submitted charges
$93K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J0630 is utilized
⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.
📊 What bills under J0630
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
9 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2025
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J0630 billing FAQ
What is HCPCS code J0630?
J0630 is a HCPCS Level II J-code used to bill Injection, calcitonin salmon, up to 400 units under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J0630?
9 NDCs currently map to J0630 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J0630 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.